National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 33324 [2021-13340]
Download as PDF
33324
Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 17, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13279 Filed 6–23–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK U24 SEP.
Date: July 9, 2021.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892.
Contact Person: Xiaodu Guo, M.D., Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 14, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13340 Filed 6–23–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:19 Jun 23, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Clinical Trials of Pharmacologic or Devicebased Interventions for Mental Disorders
(R61, R33, U01).
Date: July 14, 2021.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Jasenka Borzan, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Mental Health, 6001 Executive Blvd.,
Neuroscience Center, Room 6150, Bethesda,
MD 20892, 301–435–1260, jasenka.borzan@
nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Social Drivers of Mental Illnesses in Low- &
Middle-Income Countries: Mechanisms and
Pathways of Interventions for Youth (R01).
Date: July 15, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6149, MSC 9608,
Bethesda, MD 20892–9608, 301–443–4525,
steinerr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
Dated: June 16, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13338 Filed 6–23–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice To Announce Request for
Information (RFI) Inviting Input on
NIAAA’s 2022–2026 Strategic Plan
Outline
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Institute on
Alcohol Abuse and Alcoholism
(NIAAA) is currently developing an
updated strategic plan to highlight
priorities and guide activities for
advancing the Institute’s mission over
the next five years. Through this
Request for Information, NIAAA seeks
comments on the draft outline for its FY
2022–2026 Strategic Plan from diverse
stakeholders, including scientific
experts, health care providers, patients
and family members, advocacy groups,
other federal agencies, and nongovernmental scientific, professional,
and healthcare organizations.
DATES: Comments must be received by
July 30, 2021, to ensure consideration.
Responses will be reviewed by NIAAA
staff and considered during the
development of the 2022–2026 Strategic
Plan.
ADDRESSES: To view and comment on
the strategic plan outline, please visit
our online response form: RFI online
response form.
FOR FURTHER INFORMATION CONTACT:
Rachel I. Anderson, Strategic Plan
Coordinator, Office of Science Policy
and Communications, National Institute
on Alcohol Abuse and Alcoholism, NIH,
6700B Rockledge Drive, Bethesda, MD
20817. Telephone: 301–827–4681.
Email: NIAAASciencePolicyBranch@
nih.gov.
SUPPLEMENTARY INFORMATION: In
accordance with the 21st Century Cures
Act, NIH institutes are required to
regularly update their strategic plans.
The mission of the National Institute on
Alcohol Abuse and Alcoholism
(NIAAA) is to generate and disseminate
fundamental knowledge about the
effects of alcohol on health and wellbeing, and apply that knowledge to
improve diagnosis, prevention, and
treatment of alcohol-related problems,
SUMMARY:
E:\FR\FM\24JNN1.SGM
24JNN1
Agencies
[Federal Register Volume 86, Number 119 (Thursday, June 24, 2021)]
[Notices]
[Page 33324]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13340]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK U24 SEP.
Date: July 9, 2021.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892.
Contact Person: Xiaodu Guo, M.D., Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-4719, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: June 14, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-13340 Filed 6-23-21; 8:45 am]
BILLING CODE 4140-01-P